UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip code) |
(
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Rule 12(b) of the Act
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
At the Company’s Annual Meeting of Stockholders held on May 22, 2024, stockholders voted on three proposals and cast their votes as follows:
| 1. | The following table sets forth the names of the eight persons elected at the Annual Meeting to serve as directors until the first annual meeting of stockholders following the end of the Company’s fiscal year ending December 31, 2024, and the number of votes cast for, against or withheld with respect to each person. |
| Shares | ||||||
| Name | For | Withhold | Broker Non-Votes | |||
| David Bronson | 26,957,962 | 1,243,603 | 1,191,876 | |||
| Brian Concannon | 26,993,282 | 1,208,283 | 1,191,876 | |||
| LaVerne Council | 27,159,969 | 1,041,596 | 1,191,876 | |||
| Charles Farkas | 27,218,074 | 983,491 | 1,191,876 | |||
| Martha Goldberg Aronson | 27,365,061 | 836,504 | 1,191,876 | |||
| Curt. R. Hartman | 26,177,581 | 2,019,802 | 1,196,058 | |||
| Barbara Schwarzentraub | 27,327,255 | 874,310 | 1,191,876 | |||
| John L. Workman | 27,287,635 | 913,930 | 1,191,876 | |||
| 2. | The advisory vote on the resolution relating to compensation of our named executive officers passed based upon the following votes: |
| Shares | ||||||
| For | Against | Abstain | Broker Non-Votes | |||
| 27,090,070 | 1,069,964 | 41,569 | 1,191,838 | |||
| 3. | The appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2024 was ratified based on the following votes: |
| Shares | ||||||
| For | Against | Abstain | Broker Non-Votes | |||
| 27,290,715 | 2,097,183 | 5,543 | 0 | |||
| Item 8.01 | Other Events |
CONMED Corporation announced its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: May 22, 2024 | CONMED CORPORATION | |
| (Registrant) | ||
| By: | /s/ Todd W. Garner | |
| Name: | Todd W. Garner | |
| Title: | Executive Vice President, Finance and Chief Financial Officer | |